Skip to content

Clinical trials

Phase 1/2 Endometrial Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1/2 Country / region: Belgium Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20131
20151
20162
20172
20181
20191
20201
20212
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Active, not recruiting1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab2
Regeneron Pharmaceuticals2
Seagen Inc.2
AstraZeneca1
Clovis Oncology, Inc.1
Daiichi Sankyo1
Eikon Therapeutics1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms16
Ovarian Neoplasms13
Uterine Cervical Neoplasms7
Colorectal Neoplasms4
Melanoma4
Squamous Cell Carcinoma of Head and Neck4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Fallopian Tube Neoplasms3
Biliary Tract Neoplasms2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.